Please Wait.....
Report
Global Hypophosphatasia Treatment Market Report and Forecast 2023-2031
Market Report I 2023-04-11 I 147 Pages I EMR Inc.
Global Hypophosphatasia Treatment Market Report and Forecast 2023-2031
Global Hypophosphatasia Treatment Market Outlook
The global hypophosphatasia (HPP) treatment market is projected to grow at a CAGR of 5.10% during the forecast period of 2023-2031. The market growth can be attributed to the increasing prevalence of hypophosphatasia and the rising awareness about the disease and its treatment.
Global Hypophosphatasia Treatment Market: Introduction
Hypophosphatasia treatment refers to the medical care provided to individuals with hypophosphatasia, a rare metabolic bone disorder that affects the development and maintenance of healthy bones and teeth. The treatment options include enzyme replacement therapy, symptomatic management, and supportive care. The increasing prevalence of hypophosphatasia, along with the rising awareness about the disease and its treatment options, are expected to drive market growth.
Technological advancements have also played a significant role in the growth of the HPP treatment market. The development of novel therapies and improved diagnostic tools have made HPP treatment more effective and accessible. In addition, growing investments in research and development to explore new treatment options are expected to fuel market growth.
Global Hypophosphatasia Treatment Market- Epidemiology
Hypophosphatasia is a rare genetic disorder that occurs in various forms, ranging from severe and life-threatening to relatively mild. The disease prevalence varies based on the severity and population studied. It is estimated that the severe forms of HPP affect 1 in 100,000 live births, while milder forms may affect 1 in 6,370 individuals. The increasing prevalence of HPP and improved diagnostic capabilities are driving the demand for effective HPP treatments.
Hypophosphatasia Treatment Market Segmentations
The market can be segmented based on by type, diagnosis methods, treatment methods, treatment channel, and region:
Market Breakup by Type
- Perinatal
- Infantile
- Childhood
- Adult
- Odontohypophosphatasia
- Pseudohypophosphatasia
- Market Breakup by Treatment Type
Market Breakup by Diagnosis Method
- X-rays
- Biochemical Tests
- Chorionic Villus Sampling (CVS)
- Ultrasounds
- Vitamin B6 Test
Market Breakup by Treatment Method
- Medications
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Vitamin B6
- Others
- Dental Care
- Physical Therapy
- Occupational Therapy
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Hypophosphatasia Treatment Market Analysis
The global HPP treatment market has experienced significant growth over the past few years, driven by factors such as the increasing prevalence of hypophosphatasia, rising awareness about the disease, and growing demand for effective treatment options.
North America is currently the largest market for HPP treatment, followed by Europe and the Asia Pacific. The growth in the North American market is primarily driven by factors such as a high prevalence of hypophosphatasia, a well-established healthcare infrastructure, and strong investment in research and development. In addition, the growing adoption of novel therapies and improved diagnostic tools is further driving the growth of the market in North America.
Europe is also a significant market for HPP treatment, with countries such as Germany and France leading the way. The region's market growth is driven by factors such as a large population base, increasing awareness of HPP, and government initiatives to address rare disease concerns. Additionally, the region has a well-established healthcare system, which supports the delivery of HPP treatment. Asia Pacific is another region that is experiencing significant growth in the HPP treatment market. The region's market growth is driven by factors such as a large population base, increasing awareness of HPP, and the growing adoption of novel therapies. In addition, government initiatives to address rare disease concerns are helping to drive the growth of the market in the region.
Key Players in the Global Hypophosphatasia Treatment Market
The report provides a detailed analysis of the key players involved in the HPP treatment market, including their business overview, product portfolio, recent developments, and financial analysis. Some of the major players operating in the market include:
- Kirin Holdings Company
- Vericel Corporation
- Mereo BioPharma Group plc
- Novartis AG
- Bayer AG
- AM-Pharma B.V.
- Alexion
- Pfizer, Inc.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Hypophosphatasia Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Model
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape and Impact
6.3 Cost of Treatment
6.4 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop- out Analysis
7.3 Awareness and Prevention Gaps
8 Global Hypophosphatasia Treatment Market
8.1 Global Hypophosphatasia Treatment Market Overview
8.2 Global Hypophosphatasia Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Historical Hypophosphatasia Treatment Market Value (2016-2022)
8.2.1.2 Global Forecast Hypophosphatasia Treatment Market Value (2023-2031)
8.2.2 Global Hypophosphatasia Treatment Market by Type
8.2.2.1 Market Overview
8.2.2.1.1 Perinatal
8.2.2.1.2 Infantile
8.2.2.1.3 Childhood
8.2.2.1.4 Adult
8.2.2.1.5 Odonto-hypophosphatasia
8.2.2.1.6 Pseudo-hypophosphatasia
8.2.3 Global Hypophosphatasia Treatment Market by Diagnosis Method
8.2.3.1 Market Overview
8.2.3.1.1 X-rays
8.2.3.1.2 Biochemical Tests
8.2.3.1.3 Chorionic Villus Sampling (CVS)
8.2.3.1.4 Ultrasounds
8.2.3.1.5 Vitamin B6 Test
8.2.4 Global Hypophosphatasia Treatment Market by Treatment Method
8.2.4.1 Market Overview
8.2.4.1.1 Medications
8.2.4.1.1.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
8.2.4.1.1.2 Vitamin B6
8.2.4.1.1.3 Others
8.2.4.1.2 Dental Care
8.2.4.1.3 Physical Therapy
8.2.4.1.4 Occupational Therapy
8.2.5 Global Hypophosphatasia Treatment Market by Treatment Channel
8.2.5.1 Market Overview
8.2.5.1.1 Public
8.2.5.1.2 Private
8.2.6 Global Hypophosphatasia Treatment Market by Region
8.2.6.1 Market Overview
8.2.6.1.1 North America
8.2.6.1.2 Europe
8.2.6.1.3 Asia Pacific
8.2.6.1.4 Latin America
8.2.6.1.5 Middle East and Africa
9 North America Hypophosphatasia Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Canada
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Hypophosphatasia Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Germany
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 France
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Italy
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Others
11 Asia Pacific Hypophosphatasia Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Japan
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 India
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 ASEAN
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Australia
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
11.7 Others
12 Latin America Hypophosphatasia Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 Argentina
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Mexico
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 Others
13 Middle East and Africa Hypophosphatasia Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4 Nigeria
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
13.6 Others
14 Global Hypophosphatasia Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter's Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives, and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Kirin Holdings Company
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Vericel Corporation
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Mereo BioPharma Group plc
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Novartis AG
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Bayer AG
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 AM-Pharma B.V.
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Alexion
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Pfizer, Inc.
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
16 Hypophosphatasia Treatment Market- Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security